Log in

NYSE:LH - Laboratory Corp. of America Stock Price, Forecast & News

$177.18
-2.59 (-1.44 %)
(As of 01/24/2020 04:00 PM ET)
Today's Range
$176.90
Now: $177.18
$180.37
50-Day Range
$166.59
MA: $171.66
$180.39
52-Week Range
$135.19
Now: $177.18
$181.49
Volume556,970 shs
Average Volume621,012 shs
Market Capitalization$17.20 billion
P/E Ratio23.31
Dividend YieldN/A
Beta1.02
Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It operates in two segments, LabCorp Diagnostics (LCD) and Covance Drug Development. It offers various clinical laboratory tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C and vitamin D products, prostate-specific antigens, tests for sexually-transmitted diseases, hepatitis C tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. Read More…

Industry, Sector and Symbol

Industry Medical laboratories
Sub-IndustryHealth Care Services
SectorMedical
CUSIP50540R40
Phone336-229-1127

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$11.33 billion
Cash Flow$16.44 per share
Book Value$69.09 per share

Profitability

Net Income$883.70 million

Miscellaneous

Employees61,000
Market Cap$17.20 billion
Next Earnings Date2/13/2020 (Confirmed)
OptionableOptionable

Receive LH News and Ratings via Email

Sign-up to receive the latest news and ratings for LH and its competitors with MarketBeat's FREE daily newsletter.


Laboratory Corp. of America (NYSE:LH) Frequently Asked Questions

What is Laboratory Corp. of America's stock symbol?

Laboratory Corp. of America trades on the New York Stock Exchange (NYSE) under the ticker symbol "LH."

How were Laboratory Corp. of America's earnings last quarter?

Laboratory Corp. of America Holdings (NYSE:LH) announced its earnings results on Thursday, October, 24th. The medical research company reported $2.90 EPS for the quarter, topping the Zacks' consensus estimate of $2.85 by $0.05. The medical research company earned $2.93 billion during the quarter, compared to analysts' expectations of $2.91 billion. Laboratory Corp. of America had a return on equity of 15.33% and a net margin of 6.63%. The company's quarterly revenue was up 3.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.74 EPS. View Laboratory Corp. of America's Earnings History.

When is Laboratory Corp. of America's next earnings date?

Laboratory Corp. of America is scheduled to release their next quarterly earnings announcement on Thursday, February 13th 2020. View Earnings Estimates for Laboratory Corp. of America.

How can I listen to Laboratory Corp. of America's earnings call?

Laboratory Corp. of America will be holding an earnings conference call on Thursday, February 13th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

What price target have analysts set for LH?

13 Wall Street analysts have issued twelve-month price targets for Laboratory Corp. of America's shares. Their forecasts range from $164.00 to $220.00. On average, they expect Laboratory Corp. of America's share price to reach $189.30 in the next year. This suggests a possible upside of 6.8% from the stock's current price. View Analyst Price Targets for Laboratory Corp. of America.

What is the consensus analysts' recommendation for Laboratory Corp. of America?

13 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Laboratory Corp. of America in the last year. There are currently 2 sell ratings, 3 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Laboratory Corp. of America.

Has Laboratory Corp. of America been receiving favorable news coverage?

News coverage about LH stock has been trending extremely negative on Saturday, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Laboratory Corp. of America earned a daily sentiment score of -4.5 on InfoTrie's scale. They also assigned media stories about the medical research company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an impact on the company's share price in the near future. View News Stories for Laboratory Corp. of America.

Are investors shorting Laboratory Corp. of America?

Laboratory Corp. of America saw a decline in short interest during the month of December. As of December 13th, there was short interest totalling 1,490,000 shares, a decline of 6.3% from the November 28th total of 1,590,000 shares. Based on an average daily trading volume, of 568,200 shares, the short-interest ratio is currently 2.6 days. Currently, 1.5% of the company's shares are short sold. View Laboratory Corp. of America's Current Options Chain.

Who are some of Laboratory Corp. of America's key competitors?

What other stocks do shareholders of Laboratory Corp. of America own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Laboratory Corp. of America investors own include CA (CA), BlackRock (BLK), Amgen (AMGN), Micron Technology (MU), NVIDIA (NVDA), Endologix (ELGX), Allergan (AGN), Gilead Sciences (GILD), Chipotle Mexican Grill (CMG) and AT&T (T).

Who are Laboratory Corp. of America's key executives?

Laboratory Corp. of America's management team includes the folowing people:
  • Mr. David P. King, Chairman, CEO & Pres (Age 63)
  • Mr. Glenn A. Eisenberg, CFO & Exec. VP (Age 58)
  • Mr. F. Samuel Eberts III, Chief Legal Officer, Chief Compliance Officer, Sr. VP & Sec. (Age 59)
  • Mr. John D. Ratliff, Chief Exec. Officer of Covance Drug Devel. (Age 59)
  • Dr. Michelle Abelson, Laboratory Director of Operations

Who are Laboratory Corp. of America's major shareholders?

Laboratory Corp. of America's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Calamos Advisors LLC (0.54%), AMI Asset Management Corp (0.38%), Global Thematic Partners LLC (0.31%), Wedge Capital Management L L P NC (0.25%), PGGM Investments (0.25%) and Pwmco LLC (0.23%). Company insiders that own Laboratory Corp. of America stock include Adam H Schechter, David P King, Der Vaart Sandra D Van, Edward T Dodson, Glenn A Eisenberg, Kerrii B Anderson, Lance Berberian, Lisa J Uthgenannt, M Huff Gary, R Sanders Williams and Robert E Mittelstaedt Jr. View Institutional Ownership Trends for Laboratory Corp. of America.

Which institutional investors are selling Laboratory Corp. of America stock?

LH stock was sold by a variety of institutional investors in the last quarter, including PGGM Investments, Calamos Advisors LLC, Pwmco LLC, Zurcher Kantonalbank Zurich Cantonalbank, New York State Teachers Retirement System, Hahn Capital Management LLC, Nisa Investment Advisors LLC and Triad Investment Management. Company insiders that have sold Laboratory Corp. of America company stock in the last year include David P King, Der Vaart Sandra D Van, Glenn A Eisenberg, Kerrii B Anderson, Lance Berberian, Lisa J Uthgenannt, R Sanders Williams and Robert E Mittelstaedt Jr. View Insider Buying and Selling for Laboratory Corp. of America.

Which institutional investors are buying Laboratory Corp. of America stock?

LH stock was purchased by a variety of institutional investors in the last quarter, including Hexavest Inc., Assenagon Asset Management S.A., Wedge Capital Management L L P NC, AMI Asset Management Corp, WealthBridge Investment Counsel Inc., Birch Hill Investment Advisors LLC, Global Thematic Partners LLC and DNB Asset Management AS. View Insider Buying and Selling for Laboratory Corp. of America.

How do I buy shares of Laboratory Corp. of America?

Shares of LH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Laboratory Corp. of America's stock price today?

One share of LH stock can currently be purchased for approximately $177.18.

How big of a company is Laboratory Corp. of America?

Laboratory Corp. of America has a market capitalization of $17.20 billion and generates $11.33 billion in revenue each year. The medical research company earns $883.70 million in net income (profit) each year or $11.02 on an earnings per share basis. Laboratory Corp. of America employs 61,000 workers across the globe.View Additional Information About Laboratory Corp. of America.

What is Laboratory Corp. of America's official website?

The official website for Laboratory Corp. of America is http://www.labcorp.com/.

How can I contact Laboratory Corp. of America?

Laboratory Corp. of America's mailing address is 358 South Main Street, BURLINGTON NC, 27215. The medical research company can be reached via phone at 336-229-1127 or via email at [email protected]


MarketBeat Community Rating for Laboratory Corp. of America (NYSE LH)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  488 (Vote Outperform)
Underperform Votes:  537 (Vote Underperform)
Total Votes:  1,025
MarketBeat's community ratings are surveys of what our community members think about Laboratory Corp. of America and other stocks. Vote "Outperform" if you believe LH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel